Sign in

CIK 0001339970 · Non-accelerated filer<br>Smaller reporting company

aTYR PHARMA INC

Sign in to watch
Ticker
ATYR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
203435077
Phone
8587318389
Business address
10240 SORRENTO VALLEY ROAD, SUITE 300, SAN DIEGO, CA, 92121
  1. 4 Open-market buy President and CEO bought 10,000 shares at $4.01 ($40,100)
  2. S-8 Other Securities Offered to Employees in Benefit Plans
  3. 10-Q Report Quarterly Report
  4. 8-K Event Results of operations
  5. 8-K Event Other events
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. SC 13G/A Stake Amended Statement of Ownership
  12. SC 13G/A Stake Amended Statement of Ownership
  13. 424B5 Offering Prospectus
  14. 10-K Report Annual Report
  15. DEFA14A Proxy Proxy Materials
  16. DEF 14A Proxy Proxy Statement
  17. 8-K Event Results of operations
  18. 8-K Event Other events
  19. PRE 14A Proxy Proxy Statement (Preliminary)
  20. 4/A Derivatives Options or other derivatives

Page 14 of 38 · 755 filings